217 related articles for article (PubMed ID: 29911172)
1. PICK1-Deficient Mice Exhibit Impaired Response to Cocaine and Dysregulated Dopamine Homeostasis.
Jensen KL; Sørensen G; Dencker D; Owens WA; Rahbek-Clemmensen T; Brett Lever M; Runegaard AH; Riis Christensen N; Weikop P; Wörtwein G; Fink-Jensen A; Madsen KL; Daws L; Gether U; Rickhag M
eNeuro; 2018; 5(3):. PubMed ID: 29911172
[TBL] [Abstract][Full Text] [Related]
2. Effect of the sonic hedgehog receptor smoothened on the survival and function of dopaminergic neurons.
Zhou X; Pace J; Filichia E; Lv T; Davis B; Hoffer B; Selman W; Luo Y
Exp Neurol; 2016 Sep; 283(Pt A):235-45. PubMed ID: 27317298
[TBL] [Abstract][Full Text] [Related]
3. Mice expressing markedly reduced striatal dopamine transporters exhibit increased locomotor activity, dopamine uptake turnover rate, and cocaine responsiveness.
Rao A; Sorkin A; Zahniser NR
Synapse; 2013 Oct; 67(10):668-77. PubMed ID: 23564231
[TBL] [Abstract][Full Text] [Related]
4. Disruption of the PDZ domain-binding motif of the dopamine transporter uniquely alters nanoscale distribution, dopamine homeostasis, and reward motivation.
Sørensen G; Rickhag M; Leo D; Lycas MD; Ridderstrøm PH; Weikop P; Lilja JH; Rifes P; Herborg F; Woldbye D; Wörtwein G; Gainetdinov RR; Fink-Jensen A; Gether U
J Biol Chem; 2021 Dec; 297(6):101361. PubMed ID: 34756883
[TBL] [Abstract][Full Text] [Related]
5. Conditional, inducible gene silencing in dopamine neurons reveals a sex-specific role for Rit2 GTPase in acute cocaine response and striatal function.
Sweeney CG; Kearney PJ; Fagan RR; Smith LA; Bolden NC; Zhao-Shea R; Rivera IV; Kolpakova J; Xie J; Gao G; Tapper AR; Martin GE; Melikian HE
Neuropsychopharmacology; 2020 Jan; 45(2):384-393. PubMed ID: 31277075
[TBL] [Abstract][Full Text] [Related]
6. Low and high cocaine locomotor responding male Sprague-Dawley rats differ in rapid cocaine-induced regulation of striatal dopamine transporter function.
Mandt BH; Zahniser NR
Neuropharmacology; 2010 Mar; 58(3):605-12. PubMed ID: 19951714
[TBL] [Abstract][Full Text] [Related]
7. Novelty-induced hyperactivity and suppressed cocaine induced locomotor activation in mice lacking threonine 53 phosphorylation of dopamine transporter.
Ragu Varman D; Subler MA; Windle JJ; Jayanthi LD; Ramamoorthy S
Behav Brain Res; 2021 Jun; 408():113267. PubMed ID: 33794225
[TBL] [Abstract][Full Text] [Related]
8. Serotonin 2B Receptors in Mesoaccumbens Dopamine Pathway Regulate Cocaine Responses.
Doly S; Quentin E; Eddine R; Tolu S; Fernandez SP; Bertran-Gonzalez J; Valjent E; Belmer A; Viñals X; Callebert J; Faure P; Meye FJ; Hervé D; Robledo P; Mameli M; Launay JM; Maldonado R; Maroteaux L
J Neurosci; 2017 Oct; 37(43):10372-10388. PubMed ID: 28935766
[TBL] [Abstract][Full Text] [Related]
9. Bilateral effects of unilateral GDNF administration on dopamine- and GABA-regulating proteins in the rat nigrostriatal system.
Salvatore MF; Gerhardt GA; Dayton RD; Klein RL; Stanford JA
Exp Neurol; 2009 Sep; 219(1):197-207. PubMed ID: 19460370
[TBL] [Abstract][Full Text] [Related]
10. Lack or inhibition of dopaminergic stimulation induces a development increase of striatal tyrosine hydroxylase-positive interneurons.
Busceti CL; Bucci D; Molinaro G; Di Pietro P; Zangrandi L; Gradini R; Moratalla R; Battaglia G; Bruno V; Nicoletti F; Fornai F
PLoS One; 2012; 7(9):e44025. PubMed ID: 23028485
[TBL] [Abstract][Full Text] [Related]
11. A C-terminal PDZ domain-binding sequence is required for striatal distribution of the dopamine transporter.
Rickhag M; Hansen FH; Sørensen G; Strandfelt KN; Andresen B; Gotfryd K; Madsen KL; Vestergaard-Klewe I; Ammendrup-Johnsen I; Eriksen J; Newman AH; Füchtbauer EM; Gomeza J; Woldbye DP; Wörtwein G; Gether U
Nat Commun; 2013; 4():1580. PubMed ID: 23481388
[TBL] [Abstract][Full Text] [Related]
12. Are striatal tyrosine hydroxylase interneurons dopaminergic?
Xenias HS; Ibáñez-Sandoval O; Koós T; Tepper JM
J Neurosci; 2015 Apr; 35(16):6584-99. PubMed ID: 25904808
[TBL] [Abstract][Full Text] [Related]
13. Decreased vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) function in knockout mice affects aging of dopaminergic systems.
Hall FS; Itokawa K; Schmitt A; Moessner R; Sora I; Lesch KP; Uhl GR
Neuropharmacology; 2014 Jan; 76 Pt A(0 0):146-55. PubMed ID: 23978383
[TBL] [Abstract][Full Text] [Related]
14. Altered dopaminergic pathways and therapeutic effects of intranasal dopamine in two distinct mouse models of autism.
Chao OY; Pathak SS; Zhang H; Dunaway N; Li JS; Mattern C; Nikolaus S; Huston JP; Yang YM
Mol Brain; 2020 Aug; 13(1):111. PubMed ID: 32778145
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Tyrosine Hydroxylase Expression and Phosphorylation in Dopamine Transporter-Deficient Mice.
Salvatore MF; Calipari ES; Jones SR
ACS Chem Neurosci; 2016 Jul; 7(7):941-51. PubMed ID: 27124386
[TBL] [Abstract][Full Text] [Related]
16. Dopamine-deficient mice are hypersensitive to dopamine receptor agonists.
Kim DS; Szczypka MS; Palmiter RD
J Neurosci; 2000 Jun; 20(12):4405-13. PubMed ID: 10844009
[TBL] [Abstract][Full Text] [Related]
17. The striatal-enriched protein Rhes is a critical modulator of cocaine-induced molecular and behavioral responses.
Napolitano F; De Rosa A; Russo R; Di Maio A; Garofalo M; Federici M; Migliarini S; Ledonne A; Rizzo FR; Avallone L; Nuzzo T; Biagini T; Pasqualetti M; Mercuri NB; Mazza T; Chambery A; Usiello A
Sci Rep; 2019 Oct; 9(1):15294. PubMed ID: 31653935
[TBL] [Abstract][Full Text] [Related]
18. Single cocaine exposure does not alter striatal pre-synaptic dopamine function in mice: an [
Bonsall DR; Kokkinou M; Veronese M; Coello C; Wells LA; Howes OD
J Neurochem; 2017 Dec; 143(5):551-560. PubMed ID: 28921596
[TBL] [Abstract][Full Text] [Related]
19. Short-term atrazine exposure causes behavioral deficits and disrupts monoaminergic systems in male C57BL/6 mice.
Lin Z; Dodd CA; Filipov NM
Neurotoxicol Teratol; 2013; 39():26-35. PubMed ID: 23770127
[TBL] [Abstract][Full Text] [Related]
20. Low or high cocaine responding rats differ in striatal extracellular dopamine levels and dopamine transporter number.
Nelson AM; Larson GA; Zahniser NR
J Pharmacol Exp Ther; 2009 Dec; 331(3):985-97. PubMed ID: 19729579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
